K
Kathleen D. Liu
Researcher at University of California, San Francisco
Publications - 292
Citations - 16912
Kathleen D. Liu is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Acute kidney injury & Medicine. The author has an hindex of 56, co-authored 253 publications receiving 12602 citations. Previous affiliations of Kathleen D. Liu include University of Rochester & University of California.
Papers
More filters
Journal ArticleDOI
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
Lakhmir S. Chawla,Rinaldo Bellomo,Azra Bihorac,Stuart L. Goldstein,Edward D. Siew,Sean M. Bagshaw,D B Bittleman,Dinna N. Cruz,Zoltan H. Endre,Robert L. Fitzgerald,Lui G. Forni,Sandra L. Kane-Gill,Eric Hoste,Jay L. Koyner,Kathleen D. Liu,Etienne Macedo,Ravindra L. Mehta,Patrick T. Murray,Mitra K. Nadim,Marlies Ostermann,Paul M. Palevsky,Neesh Pannu,Mitchell H. Rosner,Ron Wald,Alexander Zarbock,Claudio Ronco,John A. Kellum +26 more
TL;DR: The Acute Disease Quality Initiative (ADQI) proposes definitions, staging criteria for AKD, and strategies for the management of affected patients, and makes recommendations for areas of future research, which aim to improve understanding of the underlying processes and improve outcomes for patients with AKD.
Journal ArticleDOI
Acute kidney injury: an increasing global concern
Norbert Lameire,Arvind Bagga,Dinna N. Cruz,Jan De Maeseneer,Zoltan H. Endre,John A. Kellum,Kathleen D. Liu,Ravindra L. Mehta,Neesh Pannu,Wim Van Biesen,Raymond Vanholder +10 more
TL;DR: Developing or progression of chronic kidney disease after one or more episode of acute kidney injury could have striking socioeconomic and public health outcomes for all countries.
Journal ArticleDOI
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury
Paul M. Palevsky,Kathleen D. Liu,Patrick D. Brophy,Lakhmir S. Chawla,Chirag R. Parikh,Charuhas V. Thakar,Ashita Tolwani,Sushrut S. Waikar,Steven D. Weisbord +8 more
TL;DR: A group of US experts in adult and pediatric AKI and critical care nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns concluded that there is insufficient evidence to support their widespread application to clinical care in the United States.
Journal ArticleDOI
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial
Jennifer G. Wilson,Kathleen D. Liu,Hanjing Zhuo,Lizette Caballero,Melanie McMillan,Xiaohui Fang,Katherine Cosgrove,Rosemary Vojnik,Carolyn S. Calfee,Jae-Woo Lee,Angela J. Rogers,Joseph E. Levitt,Jeanine P. Wiener-Kronish,Ednan K. Bajwa,Andrew D. Leavitt,David H. McKenna,B. Taylor Thompson,Michael A. Matthay +17 more
TL;DR: A single intravenous infusion of allogeneic, bone marrow-derived human MSCs was well tolerated in nine patients with moderate-to-severe ARDS, and this phase 1 trial has proceeded to phase 2 testing of M SCs for moderate to severe ARDS with a primary focus on safety and secondary outcomes including respiratory, systemic, and biological endpoints.
Journal ArticleDOI
Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy.
Katie R. Famous,Kevin L. Delucchi,Lorraine B. Ware,Kirsten N. Kangelaris,Kathleen D. Liu,B. Taylor Thompson,Carolyn S. Calfee +6 more
TL;DR: This analysis confirms the presence of two ARDS subphenotypes that can be accurately identified with a limited number of variables and that responded differently to randomly assigned fluid management.